Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic alterations of HLA-class II in ovarian cancer.

International journal of cancer - 15 Sept 2008

Kübler Kirsten, Arndt Peter F, Wardelmann Eva, Landwehr Christina, Krebs Dieter, Kuhn Walther, van der Ven Katrin

Abstract excerpt

The immune system controls tumor formation through identification and elimination of cellular alterations. Consequently, cancer development in immune competent hosts depends on strategies to evade the immune system. Modulation of tumor antigen-specific immune responses by aberrant expression of HLA-class I and II molecules is well documented in a variety of carcinomas including ovarian cancer. To date, little...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Dosage
Share to HLA-DQ Antigens
Share to HLA-DR Antigens

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HLA-DRB1 Chains

Share to Immunohistochemistry

Share to In Situ Hybridization

Share to Ovarian Neoplasms

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 18561316
DOI: 10.1002/ijc.23624

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic alterations of HLA-class II in ovarian cancer.PMID 18561316Read ↗

Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer.Semantic proximity Read ↗

HLA-class II haplotype associations with ovarian cancer.Semantic proximity Read ↗

Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms.Semantic proximity Read ↗

Clinical and biological significance of HLA-G expression in ovarian cancerSemantic proximity Read ↗

Role of altered expression of HLA class I molecules in cancer progression.Semantic proximity Read ↗

Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.Semantic proximity Read ↗

The biological consequences of altered MHC class I expression in tumours.Semantic proximity Read ↗

14-bp Insertion/Deletion Polymorphism of the HLA-G gene in Breast Cancer among Women from North Western Iran.Semantic proximity Read ↗

Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.Semantic proximity Read ↗

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sitesSemantic proximity Read ↗

High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.Semantic proximity Read ↗

The HLA crossroad in tumor immunology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.